How to Get AndroGel in California

What Is AndroGel and Why Do California Men Seek It?

AndroGel is a hydroalcoholic testosterone gel available in two concentrations: 1% (delivering 25 to 100 mg testosterone per application) and 1.62% (delivering 20.25 to 81 mg per application). AbbVie manufactures both formulations; the FDA approved the 1% product in 2000 and the 1.62% metered-pump version in 2011 under NDA 021015 and NDA 201543 respectively [1].

Testosterone deficiency affects an estimated 2 to 6% of men, with prevalence rising sharply above age 45 [2]. The T-Trials (N=788 men aged 65+, NEJM 2016) showed that testosterone treatment for one year improved sexual function scores, physical function, and self-reported vitality compared with placebo, though cardiovascular outcomes remained statistically neutral at that sample size [3].

What Hypogonadism Diagnosis Requires

The Endocrine Society's 2018 clinical practice guideline defines biochemical hypogonadism as two morning total testosterone measurements below 300 ng/dL, collected on separate days, with consistent symptoms [4]. Symptoms typically include reduced libido, fatigue, loss of muscle mass, depressed mood, and erectile dysfunction.

California prescribers follow these same diagnostic criteria. A single low reading is not sufficient; labs must be repeated because testosterone secretion is pulsatile and subject to diurnal variation of up to 35% [5].

Why Topical Gel Is Often the Starting Point

Gels produce steady-state serum levels within 24 hours and avoid the peaks and troughs associated with weekly intramuscular injections of testosterone cypionate [6]. For men who prefer not to self-inject or who have needle anxiety, AndroGel or a compounded testosterone gel offers a practical daily option.

Step-by-Step: How to Get an AndroGel Prescription in California

Getting a legal AndroGel prescription in California follows a defined clinical path. The process takes as few as three to seven days when labs are already available, or up to three weeks when labs must be ordered and prior authorization is required.

Step 1: Order or Locate Your Lab Work

You need a lab panel before any California prescriber can legally diagnose hypogonadism. Most telehealth platforms generate a lab requisition at the time of scheduling. Results from LabCorp or Quest within the last 60 days are typically accepted without redraw.

Minimum required labs at most California TRT practices:

• Total testosterone (morning draw, 7 to 10 a.m.)
• Free testosterone (equilibrium dialysis method preferred)
• Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) to differentiate primary from secondary hypogonadism
• Prostate-specific antigen (PSA) for men aged 40 and older
• Hematocrit and hemoglobin (testosterone stimulates erythropoiesis)
• Comprehensive metabolic panel
• Estradiol (baseline before therapy)

The Endocrine Society guideline specifies that PSA and a digital rectal exam should be completed in men over 40 before initiation, and that testosterone therapy is contraindicated in men with PSA above 4 ng/mL without further urologic evaluation [4].

Step 2: Schedule a Clinical Visit, In-Person or Telehealth

California Business and Professions Code §2290.5 authorizes synchronous audio-video telehealth as equivalent to an in-person visit for prescribing purposes, including controlled substances for established patients [7]. Under the DEA's temporary COVID-era telemedicine rules extended through 2025, a provider may prescribe Schedule III controlled substances (which includes testosterone) via telehealth if a valid prescriber-patient relationship exists and state law permits [8].

In practice this means a California-licensed prescriber can evaluate your symptoms, review your labs, and generate an AndroGel prescription during a video visit without you ever entering a clinic.

Step 3: Obtain a DEA-Compliant Written Prescription

AndroGel is a Schedule III controlled substance under the Controlled Substances Act [9]. California law (Health and Safety Code §11164) requires that testosterone prescriptions be written on tamper-resistant prescription forms or transmitted electronically via a CURES-compliant system [10]. Electronic prescriptions for controlled substances (EPCS) are now standard at most California pharmacies and telehealth platforms.

The prescriber must include: patient name and address, date issued, drug name and strength, quantity dispensed, directions for use, and the prescriber's DEA registration number.

Step 4: Fill the Prescription at a California Pharmacy or Ship-to-Patient

Retail chains (CVS, Walgreens, Rite Aid, Costco) and independent California pharmacies all stock AndroGel 1.62%. Average retail cost for a 30-day supply (60 pump actuations at the starting dose of 2 pumps/day) is approximately $450, $520 without insurance [11]. GoodRx coupons regularly reduce this to $90, $130 at Costco or Walmart pharmacy locations.

Licensed 503A compounding pharmacies in California may prepare compounded testosterone gel in concentrations not commercially available (commonly 2%, 5%, or 10%) when a prescriber documents a clinical rationale. The California State Board of Pharmacy oversees 503A licensure; pharmacies must comply with USP <795> standards for non-sterile preparations [12].

Telehealth Providers Prescribing AndroGel in California

California is one of the most telehealth-permissive states in the country. The state enacted explicit telemedicine parity legislation, and the Medical Board of California has issued guidance confirming that prescribing via synchronous video is legal when standard-of-care is met [7].

What a Legitimate Telehealth Visit Must Include

A compliant California telehealth visit for TRT must include:

1. A synchronous audio-video encounter (phone-only is insufficient for a new controlled-substance prescription)
2. Review of two morning testosterone lab results below 300 ng/dL
3. Symptom assessment using a validated tool such as the ADAM questionnaire or AMS scale
4. Screening for contraindications: prostate cancer history, hematocrit above 54%, severe untreated sleep apnea, or desire for fertility in the near term [4]
5. Documentation in the medical record with informed consent for testosterone therapy

Red Flags to Avoid

Avoid any platform that offers AndroGel without reviewing labs, that prescribes testosterone after a questionnaire alone, or that charges a flat monthly fee without documented clinical evaluation. The Medical Board of California has disciplined prescribers for issuing controlled-substance prescriptions without adequate evaluation [10].

Who Can Prescribe AndroGel in California?

California allows a broader set of clinicians to prescribe testosterone than many other states.

Physicians (MD and DO)

Any California-licensed MD or DO with an active DEA registration may prescribe AndroGel. Urologists, endocrinologists, and primary care internists routinely manage TRT. A specialist referral is not required.

Nurse Practitioners (NP)

California NPs who hold a Board of Registered Nursing furnishing number and a DEA Schedule III registration may prescribe AndroGel independently. Since 2023, fully independent practice authority for NPs in California under AB 890 means supervising physician agreements are no longer required for most NPs [13]. This has significantly expanded telehealth prescribing capacity for TRT in California.

Physician Assistants (PA)

California PAs may prescribe Schedule III substances under a delegation agreement with a supervising physician. The PA must hold a DEA number and document the supervising physician's authorization [14]. Most telehealth platforms employing PAs maintain these agreements on file.

Lab Requirements Before Your First AndroGel Prescription

Labs are not optional. California prescribers and payers both require objective biochemical evidence of hypogonadism before initiating testosterone therapy.

Timing Matters

Testosterone peaks between 7 and 10 a.m. Due to circadian pulsatility driven by LH secretion from the pituitary [5]. A blood draw outside this window may show artificially suppressed levels that do not represent true baseline status. The American Urological Association's 2018 guideline on testosterone deficiency explicitly states that "testosterone measurements should be obtained in the morning" [15].

Interpreting LH and FSH

Elevated LH and FSH with low testosterone indicates primary hypogonadism (testicular failure), such as from Klinefelter syndrome or prior chemotherapy. Low or normal LH with low testosterone suggests secondary hypogonadism, which may point to a pituitary or hypothalamic cause and may warrant MRI of the sella turcica before initiating TRT [4].

Monitoring Labs After Starting Therapy

After starting AndroGel, the Endocrine Society recommends checking testosterone levels 3 to 6 hours after application at 3 months to verify absorption and confirm target range (400 to 700 ng/dL) [4]. Hematocrit must be checked at 3 months and 12 months; if hematocrit exceeds 54%, therapy should be held [4]. PSA is monitored at 3 months, 6 months, and annually thereafter [15].

Medi-Cal and Insurance Prior Authorization for AndroGel in California

Medi-Cal (California Medicaid) covers AndroGel for male hypogonadism with prior authorization. Commercial insurers generally follow similar criteria.

What Prior Authorization Requires in California

A Medi-Cal PA request for AndroGel typically requires:

• Two total testosterone values below 300 ng/dL with documented collection times
• ICD-10 diagnosis code E29.1 (testicular hypofunction) or E23.0 (hypopituitarism) as appropriate
• Documentation of hypogonadism symptoms
• Prescriber attestation that the patient has no contraindications
• For men over 50: PSA value and confirmation that prostate cancer has been ruled out

The California Department of Health Care Services Drug Use Review program includes testosterone products on the Medi-Cal formulary subject to these criteria [16]. Prior authorization approvals typically take 3 to 7 business days; urgent requests may be adjudicated within 72 hours under California's Knox-Keene Act requirements.

Cost Without Insurance

Brand-name AndroGel 1.62%, 60-pump bottle (75g): approximately $450, $520 retail. Generic testosterone gel 1.62% (authorized generic by Teva and others): approximately $80, $140 with discount cards [11]. Compounded testosterone gel from a 503A pharmacy: approximately $40, $90 per month depending on concentration and volume, not covered by insurance.

The table below outlines the HealthRX California TRT Access Framework, a step-by-step decision pathway developed by the HealthRX medical team to help patients and prescribers manage common access barriers.

| Step | Action | Typical Timeline | |------|--------|-----------------| | 1 | Order morning testosterone panel (total T, free T, LH, FSH, PSA, CBC, CMP) | Day 1 to 3 | | 2 | Schedule telehealth or in-person visit after labs result | Day 3 to 7 | | 3 | Prescriber reviews labs, confirms diagnosis, issues EPCS prescription | Day 7 | | 4a (commercial Rx) | Fill at retail or online pharmacy; GoodRx applied | Day 7 to 10 | | 4b (Medi-Cal) | Prescriber submits PA; approval in 3 to 7 business days | Day 10 to 17 | | 4c (compounded) | Prescriber sends Rx to 503A pharmacy; gel prepared and shipped | Day 9 to 14 | | 5 | Confirm application technique; schedule 3-month follow-up labs | Day 90 |

Transferring an Existing AndroGel Prescription to California

Moving to California with an existing AndroGel prescription from another state involves specific legal steps because testosterone is a Schedule III controlled substance.

Can an Out-of-State Prescription Be Filled in California?

California Health and Safety Code §11200 permits a pharmacy to fill a controlled substance prescription written by an out-of-state prescriber if the prescriber holds a valid DEA registration and the prescription meets California's format requirements [10]. However, many California pharmacies have internal policies that decline out-of-state controlled-substance prescriptions as a risk-management measure.

The safest approach is to establish care with a California-licensed prescriber within 30 days of arriving in the state. A telehealth visit that includes review of your previous labs (if current) and a brief clinical evaluation can result in a new California-issued prescription the same day.

Electronic Transfer Rules

A prescription for a Schedule III substance may be transferred once between pharmacies under DEA regulation 21 CFR §1306.25 [9]. The receiving California pharmacy must receive the transfer from the original pharmacy's pharmacist directly; a patient cannot hand-carry a Schedule III transfer slip. Confirm that both pharmacies are set up for CURES reporting before initiating the transfer.

503A Compounding Pharmacies and Testosterone Gel in California

When brand-name AndroGel is cost-prohibitive or a non-standard concentration is clinically indicated, licensed 503A compounding pharmacies in California are a legal alternative.

What 503A Means

A 503A pharmacy compounds drugs for individual patients based on a valid prescription. These pharmacies are state-licensed by the California State Board of Pharmacy and must comply with federal FDCA Section 503A and California Business and Professions Code §4127 [12]. They are distinct from 503B outsourcing facilities, which compound in bulk without individual prescriptions.

Common Compounded Testosterone Gel Concentrations

Compounding pharmacies frequently prepare testosterone gel at 2%, 5%, and 10% concentrations, as well as specialty vehicles (lipoderm, PLO gel) that may improve dermal absorption. A prescriber must document a clinical rationale for the compounded product over the commercially available AndroGel; this is required by both California Board of Pharmacy regulations and USP <795> standards [12].

Shipping Rules

A California-licensed 503A pharmacy may ship a compounded testosterone preparation to a California patient at their home address. Interstate shipping of compounded Schedule III substances requires the receiving state to permit it; California pharmacies may not legally ship testosterone gel to patients in states that prohibit out-of-state controlled-substance dispensing without additional licensure.

Safety, Contraindications, and Monitoring

AndroGel carries FDA-required black-box warnings about secondary exposure: children and women who contact a treated area may absorb testosterone through skin transfer, causing virilization [1]. Patients must allow the application site to dry completely (3 to 5 minutes), cover with clothing, and wash hands immediately after application.

Absolute Contraindications

The FDA label and Endocrine Society guideline both list the following as absolute contraindications to AndroGel [1][4]:

• Known or suspected prostate cancer
• Known or suspected male breast cancer
• PSA above 4 ng/mL without urologic evaluation
• Hematocrit above 54% at baseline
• Active desire for fertility (testosterone suppresses spermatogenesis by reducing LH and FSH to near-zero)

Cardiovascular Considerations

The FDA added a label warning in 2015 requiring all testosterone products to state that venous thromboembolism risk may be increased [1]. The TRAVERSE trial (N=5,246, NEJM 2023) found that testosterone replacement in men with hypogonadism and pre-existing cardiovascular disease or high cardiovascular risk did not increase major adverse cardiovascular events (MACE) compared with placebo over a median 33 months of follow-up [17]. The trial did, however, find higher rates of atrial fibrillation, acute kidney injury, and pulmonary embolism in the testosterone arm, which the FDA reviewed in its 2024 label update [1].

For men with established cardiovascular disease, the prescriber should document a shared decision-making discussion referencing the TRAVERSE findings before initiating AndroGel [17].

Erythrocytosis Management

Testosterone stimulates erythropoiesis via EPO-independent and EPO-dependent pathways [18]. Hematocrit above 54% significantly increases blood viscosity and thrombotic risk. If hematocrit rises above 54% on AndroGel, the Endocrine Society recommends holding therapy until hematocrit falls below 50%, then restarting at a lower dose or switching to a formulation with lower systemic absorption [4].

Application Technique That Affects Efficacy

Absorption variability is the most common reason men on AndroGel fail to reach target serum levels.

Correct Application Sites for AndroGel 1.62%

The FDA-approved label for AndroGel 1.62% specifies application only to the shoulders and upper arms, not the abdomen or inner thighs [1]. Applying to unapproved sites reduces absorption predictability and increases secondary exposure risk. Apply after showering, to clean dry skin. Do not apply to the scrotum.

Dose Titration Schedule

Starting dose is 40.5 mg (two pump actuations) once daily. At 3 months, if trough testosterone (checked 3 to 6 hours post-application) is below 400 ng/dL, the prescriber may increase to 60.75 mg (three actuations) or 81 mg (four actuations). Maximum approved dose is 81 mg/day [1]. If trough exceeds 700 ng/dL, the prescriber should reduce the dose by one actuation.